French diagnostics firm Eurobio Scientific said on Wednesday that it has agreed to acquire Genome Diagnostics, also known as GenDx, for €135 million ($137.2 million) in cash.... Read More >

Agilent Technologies announced after the close of the market Tuesday that its fiscal third quarter revenues grew 8 percent year over year, topping the consensus Wall Street estimate.... Read More >

Recently, four products of Tianlong Science and Technology, including E. coli, Salmonella, Staphylococcus aureus, and Listeria monocytogenes DNA detection kits, have obtained EU CE certification. ... Read More >

Illumina and the Minderoo Foundation said on Tuesday that they have signed a partnership to commit A$40 million ($27.8 million) towards sequencing DNA in marine systems.... Read More >

Ginkgo Bioworks reported after the close of the market on Monday that its second quarter 2022 revenues grew 231 percent year over year, driven by biosecurity service revenues.... Read More >

August 11, the Second Roche Pan-Tumor Precision Diagnosis and Innovation Ecology Forum was officially opened at Roche Pharma China Shanghai Campus, where participants discussed solutions for pan-tumor precision diagnosis and treatment. ... Read More >

Becton Dickinson announced on Monday that it has inked a deal with Accelerate Diagnostics to sell that firm's Accelerate Pheno system and the Accelerate Arc module for antimicrobial susceptibility testing. ... Read More >

The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire 100 percent of Albumedix Ltd. from private investors. ... Read More >

Kingmed and Cephei China dsigned a strategic cooperation agreement in Guangzhou to jointly promote the accurate diagnosis of clinical infectious diseases such as tuberculosis, hospital-acquired infection, drug-resistant bacterial infection, and carry out long-term in-depth cooper... Read More >

Guardant Health and Thermo Fisher Scientific said on Friday that the US Food and Drug Administration has granted premarket approvals for their respective next-generation sequencing assays as companion diagnostics to Enhertu (trastuzumab deruxtecan)... Read More >